- Ionophore coccidiostats: risk of CO-selectioN of antImicrobial resistance – Clinical impact and intervention strategies (ICONIC); programma The EU Joint Programming Initiative on Antimicrobial Resistance (JPIAMR)
- The transporter of bacterial cell wall precursors: the ideal drug target; programma Priority Medicines Antimicrobiële Resistentie
- Exploiting Staphylococcus aureus sortase for anti-infective purposes; programma Priority Medicines Antimicrobiële Resistentie
- Bioprospecting for novel antibiotics; programma Priority Medicines Antimicrobiële Resistentie
- Efflux pump inhibition or cell membrane destabilization in Mycobacterium tuberculosis to enhance the activity of TB drugs and prevent drug resistance; programma Priority Medicines Antimicrobiële Resistentie
- An innovative Staphylococcal vaccine: Inhibit the inhibitor; programma Priority Medicines Antimicrobiële Resistentie
- Antibiotic combination therapies against drug resistant Gram-negative pathogens: Synergy with the innate immune system and effects on the emergence of heteroresistance; programma Antibiotica Resistentie
- Bacterial histidine kinase inhibitors as novel antibacterials with low potential for resistance development; programma Antibiotica Resistentie
- Non-conventional approaches for peptidoglycan cross-linking inhibition; Joint Programming Initiative on Antimicrobial Resistance (JPIAMR)
- REpotentiating BEta Lactam antibiotics (REBEL); Joint Programming Initiative on Antimicrobial Resistance (JPIAMR)
